Skip to main content
. 2019 Dec 9;11:779–787. doi: 10.2147/CEOR.S224277

Table 1.

Demographics of the Patient Sample, Based on Congruence with the Combinatorial Pharmacogenomic Test at Follow-Up

Full Cohort Patients on Congruent Medications Patients on Incongruent Medications p-Valuea
Total, N (% of total) 1662 (100.0%) 1301 (78.3%) 361 (21.7%)
Male, N (%) 511 (30.7%) 397 (30.5%) 114 (31.6%) 0.68
Age, Mean (SD) 53.3 (16.9) 52.6 (17.0) 55.6 (16.6) 0.003
Age <65 years, N (%) 1277 (76.8%) 1022 (78.6%) 255 (70.6%) 0.002
Total medication fills, Mean (SD) 43.8 (30.0) 42.5 (28.9) 48.2 (33.5) 0.01
Total CNS medication fills, Mean (SD) 23.5 (17.8) 22.6 (17.1) 26.7 (19.7) 0.0001
Diagnosis
 Major Depressive Disorder, N (%) 459 (27.6%) 362 (27.8%) 97 (26.9%) 0.72
 Generalized Anxiety Disorder, N (%) 318 (19.1%) 261 (20.1%) 57 (15.8%) 0.06
 Bipolar Disorder, N (%) 90 (5.4%) 69 (5.3%) 21 (5.8%) 0.71
 Other, N (%)b 1104 (66.4%) 874 (67.2%) 230 (63.7%) 0.22

Notes: ap-value patients taking medications that were congruent compared to incongruent with their test report. bRefers to patients who had non-mental health diagnoses or no diagnostic code.